SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-24-036609
Filing Date
2024-02-14
Accepted
2024-02-14 17:20:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d779591dsc13g.htm SC 13G 47604
  Complete submission text file 0001193125-24-036609.txt   49195
Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 6175162000
Bain Capital Life Sciences Opportunities III, LP (Filed by) CIK: 0001950105 (see all company filings)

IRS No.: 871325992 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 5106268331
Kyverna Therapeutics, Inc. (Subject) CIK: 0001994702 (see all company filings)

IRS No.: 831365441 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94441 | Film No.: 24640661
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)